PETHEMAPrograma para el Tratamiento de Hemopatías Malignas
References in periodicals archive ?
Phase II PETHEMA 40 patients with 2007 (21) Trial of Alternating newly diagnosed MM Bortezomib and Dexamethasone As Induction Regimen Before Autologous Stem-Cell Transplantation in Younger Patients With Multiple Myeloma Sonneveld, P.
Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukaemia: a joint study of the PETHEMA and GIMEMA co-operative groups.
Treatment with all-trans retinoic acid and anthracycline monochemotherapy for children with acute promyelocytic leukemia: a multicenter study by the PETHEMA Group.
Patients and diagnostic criteria: From I January 1985, to 31 December 1989, 178 patients with symptomatic multiple myeloma aged 70 or more years were entered into a randomized trial of PETHEMA (Programme for the Study and Treatment of Haematological Malignancies, Spanish Society of Haematology).